Drug Profile
Research programme: enzyme modulators - EpiGenX Pharmaceuticals
Alternative Names: Enzyme modulators research programme - EpiGenX PharmaceuticalsLatest Information Update: 06 Sep 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections; Cancer
Most Recent Events
- 15 Nov 1999 New profile
- 15 Nov 1999 Preclinical development for Bacterial infections in USA (Unknown route)
- 15 Nov 1999 Preclinical development for Cancer in USA (Unknown route)